Adolor Corporation
Records under this name other than patents Adolor Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,538,110 | Novel Opioid Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,278,323 | Novel Opioid Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 7,914,776 | Solid Dispersions of Opioid Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 7,700,626 | Compositions Containing Opioid Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,645,160 | Methods for Delivering a Drug to a Hospital Patient for Short-Term Use While Minimizing Long-Term Use of the Drug Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,946,262 | Methods of preventing and treating gastrointestinal dysfunction Formerly held In force · High confidence | In force | High confidence | |
| US 8,112,290 | Methods for Delivering a Drug to a Hospital Patient for Short-Term Use While Minimizing Long-Term Use of the Drug Formerly held In force · High confidence | In force | High confidence | |
| US 8,580,788 | Novel Opioid Antagonists Formerly held Term ended Term ended Oct 25, 2026 · High confidence | Term ended | Term ended Oct 25, 2026 | High confidence |
| US 8,895,560 | Novel Opioid Antagonists Formerly held Term ended Ended no later than Oct 25, 2026 · Low confidence | Term ended | Ended no later than Oct 25, 2026 | Low confidence |
| US 8,598,207 | Compositions Containing Opioid Antagonists Formerly held Term ended Term ended Jun 2, 2025 · Medium confidence | Term ended | Term ended Jun 2, 2025 | Medium confidence |